{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T12:56:18Z","timestamp":1764766578877,"version":"3.46.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.gofs.2025.10.003","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:30:18Z","timestamp":1760002218000},"page":"666-670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Place actuelle de la progest\u00e9rone et de l\u2019\u00e9chographie du col dans la pr\u00e9vention du risque d\u2019accouchement pr\u00e9matur\u00e9 en population g\u00e9n\u00e9rale"],"prefix":"10.1016","volume":"53","author":[{"given":"Patrick","family":"Rozenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.gofs.2025.10.003_bib0205","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0002-9378(90)91084-P","article-title":"Prediction of risk for preterm delivery by ultrasonographic measurement of cervical length","volume":"163","author":"Andersen","year":"1990","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.gofs.2025.10.003_bib0210","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJM199602293340904","article-title":"The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal-Fetal Medicine Unit Network","volume":"334","author":"Iams","year":"1996","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.gofs.2025.10.003_bib0215","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.jgyn.2016.09.023","article-title":"Le d\u00e9pistage universel de la longueur du col parmi les grossesses monof\u0153tales sans ant\u00e9c\u00e9dent d\u2019accouchement pr\u00e9matur\u00e9 est-il justifi\u00e9\u00a0? [Is universal screening for cervical length among singleton pregnancies with no history of preterm birth justified?]","volume":"45","author":"Rozenberg","year":"2016","journal-title":"J Gynecol Obstet Biol Reprod"},{"issue":"3","key":"10.1016\/j.gofs.2025.10.003_bib0220","doi-asserted-by":"crossref","first-page":"365.e1-5","DOI":"10.1016\/j.ajog.2015.12.020","article-title":"A universal midtrimester transvaginal cervical length screening program and its associated reduced preterm birth rate","volume":"214","author":"Son","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2025.10.003_bib0225","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/uog.19050","article-title":"Implementation of universal screening for preterm delivery by mid-trimester cervical-length measurement","volume":"53","author":"Souka","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.gofs.2025.10.003_bib0230","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/uog.26093","article-title":"Change in prevalence of preterm birth in Israel following publication of national guidelines recommending routine sonographic cervical-length measurement at 19\u201325 weeks\u2019 gestation","volume":"61","author":"Maymon","year":"2023","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2025.10.003_bib0235","doi-asserted-by":"crossref","first-page":"219.e1","DOI":"10.1016\/j.ajog.2022.07.046","article-title":"The introduction of a universal transvaginal cervical length screening program is associated with a reduced preterm birth rate","volume":"228","author":"Figarella","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"9424","key":"10.1016\/j.gofs.2025.10.003_bib0240","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(04)16351-4","article-title":"Cervical cerclage for prevention of preterm delivery in women with short cervix: randomised controlled trial","volume":"363","author":"To","year":"2004","journal-title":"Lancet"},{"issue":"9828","key":"10.1016\/j.gofs.2025.10.003_bib0245","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0140-6736(12)60030-0","article-title":"Cervical pessary in pregnant women with a short cervix (PECEP): an open-label randomised controlled trial","volume":"379","author":"Goya","year":"2012","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.gofs.2025.10.003_bib0250","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1001\/jama.2017.18956","article-title":"Effect of Cervical Pessary on Spontaneous Preterm Birth in Women With Singleton Pregnancies and Short Cervical Length: A Randomized Clinical Trial","volume":"318","author":"Saccone","year":"2017","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.gofs.2025.10.003_bib0255","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJMoa1511014","article-title":"A Randomized Trial of a Cervical Pessary to Prevent Preterm Singleton Birth","volume":"374","author":"Nicolaides","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.gofs.2025.10.003_bib0260","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/jama.2023.10812","article-title":"National Institute of Child Health and Human Development Maternal-Fetal Medicine Units (MFMU) Network. Cervical Pessary for Prevention of Preterm Birth in Individuals With a Short Cervix: The TOPS Randomized Clinical Trial","volume":"330","author":"Hoffman","year":"2023","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.gofs.2025.10.003_bib0265","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","article-title":"National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate","volume":"348","author":"Meis","year":"2003","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.gofs.2025.10.003_bib0270","doi-asserted-by":"crossref","first-page":"206.e1-9","DOI":"10.1016\/j.ajog.2011.12.026","article-title":"Prevention of preterm delivery after successful tocolysis in preterm labor by 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial","volume":"206","author":"Rozenberg","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.gofs.2025.10.003_bib0275","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMoa070641","article-title":"National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins","volume":"357","author":"Rouse","year":"2007","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.gofs.2025.10.003_bib0280","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3109\/14767051003702786","article-title":"Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Second trimester cervical length and risk of preterm birth in women with twin gestations treated with 17-\u03b1 hydroxyprogesterone caproate","volume":"23","author":"Durnwald","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"3","key":"10.1016\/j.gofs.2025.10.003_bib0285","doi-asserted-by":"crossref","first-page":"221.e1-8","DOI":"10.1016\/j.ajog.2010.12.042","article-title":"17-hydroxyprogesterone caproate for twin pregnancy: a double-blind, randomized clinical trial","volume":"204","author":"Combs","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2025.10.003_bib0290","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/AOG.0b013e31822ad6aa","article-title":"17\u03b1-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial","volume":"118","author":"Lim","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2025.10.003_bib0295","doi-asserted-by":"crossref","first-page":"194.e1-8","DOI":"10.1016\/j.ajog.2013.01.032","article-title":"Prevention of preterm delivery by 17 alpha-hydroxyprogesterone caproate in asymptomatic twin pregnancies with a short cervix: a randomized controlled trial","volume":"208","author":"Senat","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"2 Pt 1","key":"10.1016\/j.gofs.2025.10.003_bib0300","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/AOG.0b013e318193c677","article-title":"Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial","volume":"113","author":"Caritis","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2025.10.003_bib0305","doi-asserted-by":"crossref","first-page":"248.e1-9","DOI":"10.1016\/j.ajog.2010.06.016","article-title":"Failure of 17-hydroxyprogesterone to reduce neonatal morbidity or prolong triplet pregnancy: a double-blind, randomized clinical trial","volume":"203","author":"Combs","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.gofs.2025.10.003_bib0310","doi-asserted-by":"crossref","first-page":"485.e1","DOI":"10.1016\/j.ajog.2014.10.1097","article-title":"17 alpha-hydroxyprogesterone caproate does not prolong pregnancy or reduce the rate of preterm birth in women at high risk for preterm delivery and a short cervix: a randomized controlled trial","volume":"212","author":"Winer","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.gofs.2025.10.003_bib0315","doi-asserted-by":"crossref","first-page":"390.e1-8","DOI":"10.1016\/j.ajog.2012.09.013","article-title":"17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30\u00a0mm","volume":"207","author":"Grobman","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2025.10.003_bib0320","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-0039-3400227","article-title":"17-OHPC to Prevent Recurrent Preterm Birth in Singleton Gestations (PROLONG Study): A Multicenter, International, Randomized Double-Blind Trial","volume":"37","author":"Blackwell","year":"2020","journal-title":"Am J Perinatol"},{"issue":"2","key":"10.1016\/j.gofs.2025.10.003_bib0325","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1067\/mob.2003.41","article-title":"Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study","volume":"188","author":"da Fonseca","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.gofs.2025.10.003_bib0330","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/uog.5158","article-title":"Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial","volume":"30","author":"O\u2019Brien","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"10033","key":"10.1016\/j.gofs.2025.10.003_bib0335","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(16)00350-0","article-title":"Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial","volume":"387","author":"Norman","year":"2016","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.gofs.2025.10.003_bib0340","doi-asserted-by":"crossref","first-page":"e1002390","DOI":"10.1371\/journal.pmed.1002390","article-title":"Vaginal progesterone pessaries for pregnant women with a previous preterm birth to prevent neonatal respiratory distress syndrome (the PROGRESS Study): A multicentre, randomised, placebo-controlled trial","volume":"14","author":"Crowther","year":"2017","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.gofs.2025.10.003_bib0345","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1479-828X.2007.00803.x","article-title":"Progesterone for maintenance tocolytic therapy after threatened preterm labour: a randomised controlled trial","volume":"48","author":"Borna","year":"2008","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.gofs.2025.10.003_bib0350","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/1471-0528.13061","article-title":"Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial","volume":"122","author":"Martinez de Tejada","year":"2015","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.gofs.2025.10.003_bib0355","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/AOG.0000000000002065","article-title":"Progestogens for Maintenance Tocolysis in Women With a Short Cervix: A Randomized Controlled Trial","volume":"130","author":"Facchinetti","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.gofs.2025.10.003_bib0360","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJMoa067815","article-title":"Progesterone and the risk of preterm birth among women with a short cervix","volume":"357","author":"Fonseca","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.gofs.2025.10.003_bib0365","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/uog.9017","article-title":"Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"38","author":"Hassan","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.gofs.2025.10.003_bib0370","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/uog.5159","article-title":"Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial","volume":"30","author":"DeFranco","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"10280","key":"10.1016\/j.gofs.2025.10.003_bib0375","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(21)00217-8","article-title":"Evaluating Progestogens for Preventing Preterm birth International Collaborative (EPPPIC): meta-analysis of individual participant data from randomised controlled trials","volume":"397","author":"EPPPIC Group","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.gofs.2025.10.003_bib0380","doi-asserted-by":"crossref","first-page":"548.e1-8","DOI":"10.1016\/j.ajog.2009.12.005","article-title":"Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysis","volume":"202","author":"Cahill","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.gofs.2025.10.003_bib0385","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/uog.8911","article-title":"Universal cervical-length screening to prevent preterm birth: a cost-effectiveness analysis","volume":"38","author":"Werner","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.gofs.2025.10.003_bib0390","doi-asserted-by":"crossref","first-page":"554.e1-6","DOI":"10.1016\/j.ajog.2015.06.020","article-title":"Cost-effectiveness of transvaginal ultrasound cervical length screening in singletons without a prior preterm birth: an update","volume":"213","author":"Werner","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2025.10.003_bib0395","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2105\/AJPH.88.2.233","article-title":"The preterm prediction study: the value of new vs. standard risk factors in predicting early and all spontaneous preterm births","volume":"88","author":"Goldenberg","year":"1998","journal-title":"Am J Public Health"},{"issue":"2","key":"10.1016\/j.gofs.2025.10.003_bib0200","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ajog.2017.12.222","article-title":"Prevention of spontaneous preterm birth: universal cervical length assessment and vaginal progesterone in women with a short cervix: time for action!","volume":"218","author":"Campbell","year":"2018","journal-title":"Am J Obstet Gynecol"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718925003344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718925003344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T12:42:53Z","timestamp":1764765773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718925003344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2468718925003344"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2025.10.003","relation":{},"ISSN":["2468-7189"],"issn-type":[{"type":"print","value":"2468-7189"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Place actuelle de la progest\u00e9rone et de l\u2019\u00e9chographie du col dans la pr\u00e9vention du risque d\u2019accouchement pr\u00e9matur\u00e9 en population g\u00e9n\u00e9rale","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2025.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}